In the News

Recent Coverage of HMS in the News
April 12, 2016

Patients diagnosed with chronic lymphocytic leukemia who have a specific gene mutation typically don't survive longer than three years, but a drug approved Monday, based on science out of Dana-Farber, could change that. Matthew Davids (Dana-Farber) is quoted. 

April 11, 2016

Isaac Kohane (HMS) participated in an interview about Daniel MacArthur's (Mass General) study on people who remain healthy even though they carry genetic variants known to cause severe Mendelian childhood diseases. 

April 11, 2016

Jonathan Hausmann (Boston Children’s) and John Brownstein (Boston Children’s) are researching a new way to diagnose a fever called ‘feverprints,’ associated with different illnesses to help doctors make quicker and more accurate diagnoses.

April 11, 2016

The Drug Enforcement Agency announced last week that it is reviewing the possibility of reclassifying marijuana as a Schedule II drug, which would put it in the same category as Ritalin, Adderall and oxycodone. Kevin Hill (McLean) is quoted. 

April 11, 2016

David Bellinger (Boston Children's) co-authored this opinion piece offering a three-point program to end lead poisoning in the U.S. 

April 11, 2016

Allan Goroll (Mass General) authored this opinion piece about how the annual physical needs to be revitalized in the U.S. 

April 11, 2016

Dhruv Khullar (Mass General) authored this blog post about the importance of listening to patients' stories.

April 10, 2016

This article discusses the potential benefits and risks associated with the possibility of human gene editing. George Church (HMS) authored one response. 



Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.


Tell us about your awards
Share news of your achievements with the larger HMS community, click here.


Book Reviews
If you are a faculty member who has published a book recently, click here.